GLP-1 Medications and Pancreatitis: What to Know
Pancreatitis is rare but serious. Here are the warning signs and who needs caution.

The short answer
GLP-1 medication labeling includes a warning about pancreatitis (inflammation of the pancreas). It is uncommon, but it is serious, so knowing the warning signs matters. People with a history of pancreatitis need careful evaluation, and severe, persistent abdominal pain should never be ignored.
Warning signs
The classic sign is severe, persistent abdominal pain, often in the upper abdomen and sometimes radiating to the back, which may come with nausea and vomiting. If you have this, stop the medication and seek medical care promptly. Do not wait to see if it passes.
Ready to start?
$199 Skeptics’ Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trialWho needs extra caution
Tell your physician if you have had pancreatitis, gallstones, high triglycerides, or heavy alcohol use, since these affect risk and the plan. This is exactly the kind of history a real medical review screens for, which is why supervision matters more than a quick online form.
How this relates to what we offer
Our $119 review screens your history, including pancreatitis risk factors, and we give clear guidance on the warning signs so you know when to seek care.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.
Frequently asked questions
Can GLP-1 medications cause pancreatitis?
GLP-1 labeling includes a pancreatitis warning. It is uncommon but serious. Severe, persistent abdominal pain (sometimes radiating to the back) needs prompt medical attention, and you should stop the medication.
What are the warning signs of pancreatitis?
Severe, persistent abdominal pain, often upper abdomen and sometimes radiating to the back, possibly with nausea and vomiting. Seek care promptly and do not wait.
Who should be cautious about pancreatitis on a GLP-1?
People with a history of pancreatitis, gallstones, high triglycerides, or heavy alcohol use. Tell your physician so they can screen and decide what is safe.
Is pancreatitis common on these medications?
No, it is uncommon, but because it is serious, knowing the warning signs and getting screened beforehand is important.
Does New Hope screen for pancreatitis risk?
Yes. The $119 review screens your history, including pancreatitis risk factors, and we explain the warning signs so you know when to seek care.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.